Camille Sebaaly
2023
In 2023, Camille Sebaaly earned a total compensation of $695K as Chief Financial Officer at Sunshine Biopharma, a 25% decrease compared to previous year.
Compensation breakdown
| Bonus | $380,000 |
|---|---|
| Salary | $315,000 |
| Total | $695,000 |
Sebaaly received $380K in bonus, accounting for 55% of the total pay in 2023.
Sebaaly also received $315K in salary.
Rankings
In 2023, Camille Sebaaly's compensation ranked 1,546th out of 2,709 executives tracked by ExecPay. In other words, Sebaaly earned more than 42.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,546 out of 2,709 | 43rd |
Division Manufacturing | 909 out of 1,488 | 39th |
Major group Chemicals And Allied Products | 580 out of 835 | 31st |
Industry group Drugs | 564 out of 801 | 30th |
Industry Pharmaceutical Preparations | 395 out of 570 | 31st |
Source: SEC filing on October 17, 2024.
Sebaaly's colleagues
We found two more compensation records of executives who worked with Camille Sebaaly at Sunshine Biopharma in 2023.